Aquestive Therapeutics (AQST) Retained Earnings (2017 - 2025)
Historic Retained Earnings for Aquestive Therapeutics (AQST) over the last 9 years, with Q3 2025 value amounting to -$415.1 million.
- Aquestive Therapeutics' Retained Earnings fell 1992.7% to -$415.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$415.1 million, marking a year-over-year decrease of 1992.7%. This contributed to the annual value of -$363.2 million for FY2024, which is 1383.27% down from last year.
- Latest data reveals that Aquestive Therapeutics reported Retained Earnings of -$415.1 million as of Q3 2025, which was down 1992.7% from -$399.7 million recorded in Q2 2025.
- In the past 5 years, Aquestive Therapeutics' Retained Earnings ranged from a high of -$200.9 million in Q1 2021 and a low of -$415.1 million during Q3 2025
- In the last 5 years, Aquestive Therapeutics' Retained Earnings had a median value of -$311.0 million in 2023 and averaged -$309.7 million.
- Per our database at Business Quant, Aquestive Therapeutics' Retained Earnings plummeted by 4282.77% in 2021 and then tumbled by 252.89% in 2023.
- Quarter analysis of 5 years shows Aquestive Therapeutics' Retained Earnings stood at -$256.8 million in 2021, then decreased by 21.19% to -$311.2 million in 2022, then decreased by 2.53% to -$319.1 million in 2023, then fell by 13.83% to -$363.2 million in 2024, then dropped by 14.3% to -$415.1 million in 2025.
- Its Retained Earnings stands at -$415.1 million for Q3 2025, versus -$399.7 million for Q2 2025 and -$386.1 million for Q1 2025.